Cargando…
Combatting Fibrosis: Exosome‐Based Therapies in the Regression of Liver Fibrosis
Hepatic fibrosis results from chronic injury and inflammation in the liver and leads to cirrhosis, liver failure, and portal hypertension. Understanding the molecular mechanisms underlying hepatic fibrosis has advanced the prospect of developing therapies for regression of the disease. Resolution of...
Autores principales: | Chen, Li, Brenner, David A., Kisseleva, Tatiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357832/ https://www.ncbi.nlm.nih.gov/pubmed/30766956 http://dx.doi.org/10.1002/hep4.1290 |
Ejemplares similares
-
Inactivation of myofibroblasts during regression of liver fibrosis
por: Kisseleva, Tatiana, et al.
Publicado: (2013) -
The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma
por: Baglieri, Jacopo, et al.
Publicado: (2019) -
The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts
por: Liang, Shuang, et al.
Publicado: (2016) -
Promising Therapy Candidates for Liver Fibrosis
por: Wang, Ping, et al.
Publicado: (2016) -
Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation
por: Lan, Tian, et al.
Publicado: (2015)